Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1146575 | 1.00 | TLR7 (0.79) | TLR7IL6 | |
| SCHEMBL12800829 | 0.96 | TLR7 (0.76) | TLR7IL6 | |
| SCHEMBL1146336 | 0.91 | TLR7 (0.80) | TLR7IL6 | |
| SCHEMBL1146510 | 0.91 | TLR7 (0.66) | TLR7IL6 | |
| SCHEMBL1146212 | 0.91 | TLR7 (0.79) | TLR7IL6 | |
| SCHEMBL12800886 | 0.91 | TLR7 (0.76) | TLR7IL6 | |
| SCHEMBL12800186 | 0.91 | TLR7 (0.76) | TLR7IL6 | |
| SCHEMBL12800359 | 0.91 | TLR7 (0.70) | TLR7IL6 | |
| SCHEMBL15177549 | 0.91 | TLR7 (0.70) | TLR7IL6 | |
| SCHEMBL1146255 | 0.90 | TLR7 (0.76) | TLR7IL6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119455003-A | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119455004-A | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-113660957-B | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-116457023-A | antibody-TLR agonist conjugates, methods and uses thereof | AMBRX公司 | 2023-07-18 | — | — | CN | disclosed |
| EP-4199968-A1 | ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF | Ambrx, Inc. (US) | 2023-06-28 | — | — | EP | disclosed |
| WO-2022040596-A1 | ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF | AMBRX, INC. (US) | 2022-02-24 | — | — | WO | disclosed |